Personalized Atrial Fibrillation Ablation With QDOT

Clinical trial NCT04298177 · UNKNOWN

Trial details

NCT number: NCT04298177
Sponsor: Antonio Berruezo, MD, PhD
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Atrial Fibrillation

Start date: 2022-03-01
Primary completion: 2022-12-01
Enrollment: 77

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.